Geographical Focus

Together, we are establishing a sustainable platform for radiopharmaceutical production, training, and innovation across the Balkans and Europe.

Ifigeneia_map

Geographical Focus

Together, we are establishing a sustainable platform for radiopharmaceutical production, training, and innovation across the Balkans and Europe.

Ifigeneia_map

Main Hubs

Greece     LINAC design, Beam dynamic studies, Beam parameters and HW specifications, Safety and radiation protection requirements, Small scale LINAC prototype, Pilot in health and culture.

Slovenia     Controls, Lab condition development, Isotopes identification, Ligands investigation, Pilot pre-clinical studies.

Cyprus     Exploitation Strategies, Business Plan, Investment Plan, Private Equity.

Mentorship for Western Balkans

Bosnia and Herzegovina     Support for future excellence hubs: Mentoring activities, Knowledge transfer.

International collaboration

CERN, DKFZ, GSI      Ensuring scientific excellence and regional impact.

Over 20 partners from 6 countries

The project fosters cross-sectoral cooperation between academia, healthcare, industry, and cultural institutions, while promoting an inclusive approach that actively involves civil society and public actors.

Tehnopolis
Cosylab
Cosylab
IAS
Univesity of Cyprus
OKYnY
GSI
CERN

Meet the team

The IFIGENEIA project kicked off in early April 2025 in Thessaloniki, Greece, with a dynamic meeting where all project partners met for the first time.

Detailed description of all partners

Partners-22
Aristotle University of Thessaloniki

The Aristotle University of Thessaloniki (AUTh), the largest university in Greece, was founded in 1925. It comprises 10 faculties which consist of 41 schools. with almost 2,000 faculty members and 95,000 students.
The strategic objectives of AUTh, in the framework of its vision and mission, remain high and consistently oriented to the continuation of its tradition, namely, to be a pioneer institution on all levels: education, research, culture, and connection with society.
A key competitive advantage of AUTh is its multidisciplinary character, as it covers the full range of sciences, engineering, health sciences, humanities, and the arts. This broad academic scope fosters interdisciplinary education and research, promotes innovation, and cultivates essential skills for students.
AUTh enjoys high international recognition, consistently ranking among the top 400–500 universities worldwide and leading Greek universities. Its academic excellence is reflected in numerous international collaborations, agreements with foreign institutions, and the successful career paths of its graduates both in Greece and abroad. It has a long-standing tradition of high-impact research, active participation in European and international projects, and numerous collaborations with academic and research institutions worldwide.

More info: https://www.auth.gr/en/homepage/

Partners-22
Region of Central Macedonia

The Region of Central Macedonia (RCM) is one of the thirteen administrative regions of Greece and the second most populous in the country. Located in Northern Greece, it includes seven regional units: Thessaloniki, Imathia, Kilkis, Pella, Pieria, Serres, and Halkidiki. With Thessaloniki as its capital, the region serves as a vital political, economic, and cultural hub in Southeast Europe. Central Macedonia has a diverse landscape combining mountains, plains, lakes, and a long coastline, making it a popular destination for tourism, agriculture, and trade. RCM plays a key role in regional development, innovation, and cross-border cooperation, actively participating in numerous European projects and initiatives. The Region is strongly committed to improving public health services, promoting integrated care models, and advancing digital health solutions in collaboration with local health authorities, academic institutions, and civil society. Through strategic planning and targeted actions, RCM supports sustainable development, social inclusion, and enhanced quality of life for all citizens.

More info: https://www.pkm.gov.gr/

Partners-22
BIOKOSMOS SA

The company BIOKOSMOS S.A. was established in November 1992 with a view to fully cover the needs of the Greek medical community in the field of Oncology and Nuclear Medicine through a high level of services.
In 2000, it moved forward to realize the biggest advanced-technology investment that has ever happened until now in the field of medical molar nuclear imaging in Greece, by installing the first cyclotron for the production of short-lived radioisotopes and radiopharmaceuticals. After three or more years of intensive research, in cooperation with academic institutions, internationally acclaimed scientists and highly specialized people in the field of construction, as well as on the institutional level, this high-cost investment was fulfilled and became fully operational. Since 2004, it has been producing radiopharmaceuticals for PET/CT tests in its state-of-the-art facilities, which are seen as a reference point by the European Community of radiopharmaceuticals and are frequently visited by researchers, trainees and students for the purposes of their post-graduate studies.
At the same time, it has obtained a license for the production of radiolabelled compounds, a license for the distribution and transportation of the manufactured radiopharmaceuticals (both licenses are issued by the Greek Atomic Energy Commission), a license for operating a factory for pharmaceuticals, a license for manufacturing of radiopharmaceuticals, a GMP certificate for radiopharmaceuticals (these licenses and certificates are issued by the National Organization for Medicines).
Today, the company manufactures and delivers radiopharmaceuticals on a daily basis, even for orders placed just one day in advance, while it has already created a 2nd production unit in Northern Greece.

More info: https://www.biokosmos.gr/

Partners-22
Archaeological Museum of Thessaloniki

Archaeological Museum of Thessaloniki is one of the largest museums in Greece and the central museum of northern Greece. Its story follows the course of history of the modern city of Thessaloniki. Its mission is the housing, protection, documentation, study, publication and exhibition of Heritage Artefacts of Ancient Macedonia. It also participates in Research and Educational Programs. Its personnel consists of 54 professionals of different specialties from archaeologists, architects and chemists to computer scientists and graphic designers. Its exhibitions cover a wide range of the history of ancient Macedonia from Prehistory to the Hellenistic and Late Roman period. Intention was to shed light on the different sides of the culture that was created in Macedonia, mainly in Thessaloniki and the adjacent municipalities: from the beginning of prehistoric times up until the late antiquity, meaning the beginning of the Christian era. Archeological Museum of Thessaloniki is the only public museum in Greece that houses a Department of Physicochemical Research & Archaeometry. The Analytical Lab deals with: i) The non-invasive analysis of ancient artefacts and the implementation of complementary sampling analytical techniques. ii)The study of ancient technology through the determination of chemical composition. iii) The study of the pathology. iv)The study of authenticity. v) It supports, also, the conservation program of the Museum.

More info: www.amth.gr

Cosylab
Centre for Research and Technology Hellas

The Centre for Research and Technology Hellas (CERTH) was fοunded in March 2000, it is a legal entity governed by private law with non-profit status, supervised by the General Secretariat for Research and Innovation (GSRI) of the Greek Ministry of Development. CERTH suggests one of the most important Research Centers in Greece with a main mission: The promotion of innovative research for the benefit of society. Dedicated to this purpose, CERTH lies at the forefront of basic, applied and technological research to provide solutions to society’s modern challenges.
The Information Technologies Institute of CERTH (CERTH/ITI) is one of the leading Institutions of Greece in the fields of Informatics, Telematics and Telecommunications, with long experience in numerous European and national R&D projects. It is active in a large number of application sectors (energy, buildings and construction, health, manufacturing, robotics, (cyber)security, transport, smart cities, space, agri-food, marine and blue growth, water, etc.) and technology areas such as data and visual analytics, data mining, machine and deep learning, virtual and augmented reality, image processing, computer and cognitive vision, human computer interaction, IoT and communication technologies, navigation technologies, cloud and computing technologies, distributed ledger technologies (blockchain), (semantic) interoperability, system integration, mobile and web applications, hardware design and development, smart grid technologies and solutions and social media analysis.

More info: www.certh.gr

Cosylab
Papageorgiou General Hospital

Geniko Nosokomeio Papageorgiou (GNP) is a prominent healthcare provider in Northern Greece, dedicated to delivering high quality patient care and staying abreast of the latest advancements in healthcare technologies. A non-profit private law entity fully integrated into the National Health System, under the supervision of the Ministry of Health and governed by a seven-member Board of Directors. The GNP, provides medical services to adult and paediatric patients, including nuclear medicine and radiotherapy. It is closely linked to the research and educational activities of AUTH, mainly the Medical School, but also to the Faculty of Sciences.
Research at Papageorgiou Hospital is focused on answering important health questions and transforming new findings into benefits for patients and society. With more than 2.000 staff and trainees, research extends to a great spectrum of health science, from basic molecular biology, to translational research, clinical trials and health care services. All medical physics activities are organised through the Medical Physics Department.
GNP hospital is an impressive facility with a wide range of clinics including an outpatient clinic with the capacity to deal with 1,200 patients per day and 300,000 per year. There are specialised sections including one for radiotherapy. It has ultramodern facilities: full computerisation; tele-consultation system; closed-circuit television in the operating theatres linked to meeting rooms and the lecture theatre for medical congresses; medical imaging equipment like an MRI Scanner-one more to be added soon- and a PET/CT scanner, two computerised tomography system, an angiography and two cardiovascular angiography systems, two Linacs with photon and electron beams, a high dose rate brachytherapy unit etc.
Papageorgiou hospital has also a fully equipped and licenced Experimental and Research centre (www.rcph.gr). It includes an animal facility unit (rodents and rabbits) and an experimental surgery unit. It is fully accredited as a legal ‘ breeding, supplying and experimental animal research unit’ according to the revised national (PD 56/2013) and European legislation (2010/63/ΕE).
GNP is committed to educating and training its staff on modern technologies. Additionally, it is focused on fostering collaborations with academic institutions to train the future workforce and to provide contemporary projects for education and research purposes. As an end-user, is a key pillar to promote to medical communities the dissemination of project’s results and upcoming advanced methods leading to long-term optimisation of services for patients. It provides the possibility for future follow up of related research at its research infrastructure, in particular since several members of its medical personnel are also professors at AUTH, and can involve students. Hence, it has the potential to facilitate the incorporation of technological innovation in clinical practice for the benefit of professionals and patients.

More info: https://www.papageorgiou-hospital.gr/

Tehnopolis
Technopolis ICT Park

Technopolis ICT Park (TPOLIS) located in Thessaloniki-Greece, is Greece’s first private ICT Business Park, established in 2001 to foster innovation and entrepreneurship in the digital economy. It serves as a dynamic ecosystem where research-intensive SMEs, academic institutions, and technology stakeholders collaborate to enhance competitiveness, digital literacy, and investment opportunities. By bridging local and international networks, TPOLIS continues to drive technological advancements and business growth.
TPOLIS puts a strong emphasis on research, development, and knowledge transfer to enable synergies among enterprises and research centers. It serves as a catalyst for cross-sector and cross-border collaboration, supporting digital transformation and strengthening ties between industry, academia, and policymakers.
It is recognized as a best-practice model for the successful integrattion of private and public investment to accelerate innovation. Furthermore, it operates the TPOLIS Incubator, which focuses on the ICT sector, and provides startup support, mentorship, and funding opportunities to drive entrepreneurial success.
TPOLIS has a track-record of participation in national and European projects, contributing expertise in entrepreneurship, cooperation, startup growth, and technology training. Its commitment to outreach and knowledge dissemination ensures that advancements in innovation are effectively utilized for economic and scientific development.

More info: https://technopolis.gr

Partners-22
National Center for Scientific Research “DEMOKRITOS”

The National Center for Scientific Research “Demokritos” (NCSR-D) is the largest multidisciplinary research center in Greece, with critical mass in expertise and infrastructure in the fields of Energy & Environment, Nanotechnology, Biosciences, Particle and Nuclear Science, Informatics and Telecommunications. The NCSR-D conducts excellent basic and applied research and plays a pivotal role in graduate education and professional training, while its unique infrastructure is also providing high-technology services to the Industry and the Society.
The Institute of Nuclear and Particle Physics (INPP), at NCSR Demokritos, has as its mission the experimental and theoretical research, scientific excellence and innovation in High-Energy Physics, Nuclear Physics and Astro-Particle Physics as well as their applications in line with the National Research and Innovation Strategy for Smart Specialisation. The experimental and theoretical research in High Energy Physics focuses on the study of elementary particles and their interactions participating in the CMS and ATLAS experiments of the LHC at CERN. The Astro-Particle Physics group participates in the development, deployment, data acquisition and data analysis of the kilometre cube underwater neutrino telescope in the Mediterranean, KM3NeT. The Nuclear Physics group particpating in Ifigeneia project performs research focused on Nuclear Structure, Nuclear Reactions, Nuclear Astrophysics, fundamental and applied X-ray spectrometry studies. The INPP hosts CALIBRA, a unique national infrastructure equipped with a 5.5 MV Tandem accelerator, open to external users from Greece and abroad with innovative applications covering the fields of cultural heritage, environment, energy, human health and the development and testing of advanced materials and detectors. CALIBRA hosts the XRF laboratory focusing on cultural heritage studies and environmental monitoring offering technology transfer and on-site analytical services to museums, archaeological sites and other institutions.
The Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety (INRASTES) is an interdisciplinary R&D establishment pursuing basic, translational and applied research to address challenges of great scientific and socioeconomic impact in a broad spectrum of scientific and technological fields. The research activities of the INRASTES Radiopharmacy teams, involved in the IFIGENEIA project, aim at the development of novel radioactive drugs, termed “radiopharmaceuticals,” for application in molecular imaging and targeted radionuclide therapy. Anchored in decades of collaboration with nuclear medicine departments and bolstered by state-of-the-art equipment, our scientific teams specialize in tailoring high-affinity vectors—ranging from small organic molecules, peptides and peptidomimetics to antibodies, polymers and multifunctional nanoparticles—to disease-associated targets such as enzymes, receptors and transporters. By conjugating these vectors to a spectrum of diagnostic radionuclides (⁹⁹ᵐTc, ⁶⁸Ga, ¹⁸F, ⁸⁹Zr) and therapeutic isotopes (¹⁷⁷Lu, ²²⁵Ac), we forge “theranostic” probes capable of precise in vivo localization and effective eradication of pathological foci. State-of-the-art HPLC, radio-TLC, γ-counter and capillary electrophoresis platforms enable exhaustive physicochemical and radiochemical purity assessments, while our licensed animal facilities underpin robust preclinical models. Through iterative lead optimization—refining chemical structure, pharmacokinetics and biodistribution—we aim to advance the most promising candidates in close collaboration with industrial, clinical and regulatory partners. As a testament to our translational focus, we hold national marketing authorizations for three radiopharmaceuticals—Rhenium-186 Sulphide Colloid, ⁹⁹ᵐTc(V)DMSA and ⁹⁹ᵐTc-MIBI—and continue to pioneer innovations in radiolabeled nanoparticles for nanobrachytherapy and beyond, all under stringent EU and Greek guidelines for medicinal products, radioprotection and waste management.

More info: http://www.inp.demokritos.gr/

Partners-22
ANGELOS LAMPOUDIS KAI SIA OE (YFOS)

YFOS is a state-of-the-art, second-generation manufacturing facility located in Kavalari, Thessaloniki, specializing in the design and production of high-precision composite components utilizing both metallic and non-metallic materials. Leveraging a combination of advanced manufacturing technologies and a highly skilled workforce, YFOS is committed to delivering exceptional quality and responsive service tailored to the unique needs of its clients.
The facility is equipped with two advanced CNC machining centers and maintains a strong collaboration with the Aristotle University of Thessaloniki (AUTH) for high-precision metrology and quality assurance. YFOS continues to demonstrate excellence in precision engineering, contributing to complex scientific projects at the international level.

More info: https://www.yfos.gr/

Partners-22
Faculty of Medicine, University of Ljubljana

The University of Ljubljana is Slovenia’s largest and most prominent educational and research institution, with nearly 7,000 staff members dedicated to advancing knowledge and innovation. Renowned for its high-quality study programs across diverse fields—including natural sciences, medicine, and engineering—the university fosters interdisciplinary and multidisciplinary education through collaborations with top international universities. It encompasses 26 faculties, each contributing to its vibrant academic community.
One of its key faculties is the Faculty of Medicine, Slovenia’s leading institution in medical and dental education, serving as a hub for education, innovative research, and healthcare diagnostics. The Faculty of Medicine actively partners with renowned medical institutions worldwide and participates in numerous domestic, European, and international projects aimed at advancing medical research and healthcare diagnostics. The Division of Nuclear Medicine at the University Medical Centre Ljubljana is a multidisciplinary unit that brings together experts in medicine, radiopharmacy, chemistry, and physics. It plays a key role in clinical, research, and translational work at both national and international levels, contributing to high-quality patient care, education, and innovation. For the purposes of the project, selected experts from this field, with a focus on translational research, have joined the Faculty’s research team, thereby strengthening its capacity for advanced interdisciplinary collaboration.

More info: https://www.mf.uni-lj.si/en_GB

Cosylab
Jožef Stefan Institute

The Jožef Stefan Institute (IJS) is the leading Slovenian research organization dedicated to science and technology. It conducts research across a wide range of fields, including natural sciences, engineering, biotechnology, and information sciences. Established in 1949, the Institute is named after the renowned Slovenian physicist Jožef Stefan, best known for the Stefan-Boltzmann law. IJS employs over 1,200 researchers, engineers, doctoral students, and support staff, working in numerous laboratories and research units. It consists of 28 research departments as well as several centers and other units, operating at five locations. In 2024, the Institute participated in 769 research projects, including 13 funded by the European Research Council (ERC). In terms of scientific excellence, IJS published more than 1,060 scientific papers, which have collectively received over 60,000 citations. The Institute is strongly engaged in international research collaboration and plays a key role in transferring knowledge and technologies to industry, while also fostering the education of young scientists—by the end of 2024, 835 young researchers were employed at IJS. Beyond its research activities, IJS actively contributes to the development of science policy, the green and digital transition, and the popularization of science in society. Its mission is to generate new knowledge, develop advanced technologies, and support innovation and entrepreneurship. The Institute is also a key player in Slovenia’s digital and green transformation. In addition to research, it offers education and training for young scientists and participates in the shaping of national science policy. Acting as a bridge between science, industry, government, and the educational sector, IJS contributes to both social and economic progress through its scientific excellence and innovation.

more info: https://www.ijs.si/

Cosylab
Cosylab, d. d., Control System Laboratory

Cosylab is the leading provider of foremost expertise, turnkey software solutions, and electronics for the world’s most advanced systems and devices, such as particle accelerators, fusion reactors, quantum devices, semiconductor manufacturing subsystems and innovative radiation therapy systems.
Our turnkey software solutions enable organisations to make scientific breakthroughs, deliver state-of-the-art cancer treatments, bring clean fusion energy to the world, create novel quantum devices and be the first to market with their semiconductor manufacturing solutions. Our engineering is integrated into the most significant Big Science international projects, including CERN and ITER.
With our unique end-to-end capabilities, we help organisations of all sizes and scopes accelerate development and shorten time-to-market. We always put in the effort to understand our clients’ unique challenges in accelerator projects and meet them with tailored collaboration and solutions.
Additionally, our experienced engineers and project managers can always supplement your team, ensuring your project meets quality demands and deadlines without compromise.
Particle accelerators constantly evolve with new technology, requiring significant effort to maintain reliability and performance. With decades of experience in control systems for all accelerator types, Cosylab helps clients mitigate development risk, shorten delivery time, and reduce the total cost of ownership.
From our headquarters in the EU and subsidiaries across Europe, North America and Asia, we have worked on hundreds of multi-year and multi-people projects worldwide.

More info: https://cosylab.com/

Partners-22
Slovenian Innovation Hub, European Economic Interest Grouping

SIH EEIG acts as a lighthouse within the European innovation ecosystem, guiding businesses, research institutions, and other stakeholders working with advanced technologies toward smoother and faster transitions to higher Technology Readiness Levels (TRLs). By bridging the critical “innovation valley of death,” SIH EEIG enables the effective translation of scientific knowledge into real-world applications. With its extensive expertise, broad international network, and transdisciplinary approach, it supports partners in navigating complex innovation processes, overcoming systemic barriers, and illuminating their path to sustainable and competitive success.
SIH EEIG is the national coordinator of the Strategic Research and Innovation Partnership (SRIP) for Health – Medicine, an initiative within Slovenia’s Smart Specialisation Strategy (S5). The partnership focuses on driving innovation in key domains such as cancer treatment, personalized medicine, biopharmaceutical development, active and healthy ageing, and natural health-based products and cosmetics.
Beyond SRIP implementation, SIH EEIG:
• Coordinates Reference Site Slovenia 3* within the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA), promoting wellbeing and healthy lifestyles as essential pillars of the silver economy;
• Participates in two pilot projects under the Smart Health dimension of the Vanguard Initiative, fostering interregional innovation collaboration;
• Is a member of Medic Nest, a European platform for precision medicine development.
SIH EEIG provides comprehensive project support across all phases—from opportunity assessment and consortium building to proposal development and implementation—tailored to EU and national funding contexts. Its services enable high-impact partnerships and improve visibility, positioning its members for long-term success in competitive innovation environments.
The organization is actively involved in several EU-funded projects, including IN-4-AHA (H2020), Senior Eco-Nect (HORIZON EIE), HealthChain and GeneH (WIDERA), enhancing cross-border collaboration, co-creation, and knowledge transfer.
SIH EEIG is a long-standing partner in multiple European and global innovation networks such as ECCP, ECHAlliance, SBRA, Vanguard Initiative, RSCN, and is a founding member of the Twins International Multihelix (TIM) metacluster, with presence across Europe, North America, and Asia.
Through its strategic, systemic, and inclusive approach, SIH EEIG strengthens Slovenia’s innovation capacity and international competitiveness while supporting transformative, transdisciplinary, and sustainable development.

More info: https://sis-egiz.eu/

Partners-22
The Slovenian Academy of Engineering

The Slovenian Academy of Engineering was established in 1995 by a group of Slovene scientists from the area of engineering and natural sciences. In December 2006, the National Assembly of the Republic of Slovenia adopted the Law on the Slovenian Academy of Engineering. We are a National Academy. In 2025 SAE has 55 full members, 30 associated Members, 20 foreign members and 7 honorary members (2 Nobel Prize Winners).
Objectives of the Academy
To promote Slovene innovation, development and engineering sciences; To promote the role and influence of engineers in our society especially when dealing with issues related to economy and development; To contribute to Slovene strategic planning of research, education, technology and innovation; To propose actions, programs and projects leading to better quality of research and technology transfer; Promote and develop „Technology highway“ program of cooperation between businness, innovation and technology; To develop international cooperation.
Main Activities
Organistaion or participation of national and international panel discussions, conferences, round tables and other meetings in area of engineering and business sciences and disciplines; Publishing of annual reports , round table proceedings and „Progress oriented“ brochure; Analysing annual status of Education, Research, Innovation, Patents and Enterprises in Slovenia compared to international community; Cooperate with relevant national bodies and international associations of academies, institutions and companies in technical science.
SAE is a member of CAETS – International Council of Academies of Engineering and Technical Sciences and a member of Euro-CASE – The European Council of Academies of Applied Sciences and Engineering.

More info: www.ias.si

Partners-22
RTD TALOS LIMITED

RTD Talos Development Organization was established in September 2000. RTD Talos was founded in a period when the global economic environment was changing into a new economy, and Cypriot businesses, especially small and medium ones, were facing major competitiveness problems. At the same time, the Cypriot government was initially facing the challenge of harmonizing with the Community acquis and later implementing its development policy within the broader European effort.

RTD Talos has been following a dynamic course of development since its foundation and quickly established itself as one of Cyprus’s reliable partners in the consulting services market. RTD Talos early diagnosed the need to connect the Cypriot economy with the broader European market and emphasized exploiting the prospects opening up through the full integration of Cyprus into the European Union.

RTD Talos, ran by a team of young scientists and a dynamic network of external partners, develops a full range of support and consulting services to:
– The Cypriot government, in matters of economic, social, and development policy, innovation, and small and medium enterprises,
– Cypriot businesses emphasize strategy, research, innovation, and technological development.

The main goal of Talos’ efforts is to help Cypriot businesses to:
– take advantage of the opportunities offered by their integration into the European Economy,
– develop new products, services, and processes,
– increase their market share,
– strengthen their existing infrastructure,
– increase their entrepreneurial capacity,
– reduce the cost of managing their operations,
– strengthen their competitiveness,
– improve the quality of their services and products,
– acquire a greater orientation towards the requirements of the unified European market.

Currently RTD Talos is a partner in 17 consortiums, out of which 13 run HORIZON EUROPE projects and it has a dynamic and growing present in the local consulting market.

More info: https://www.talos-rtd.com/

Univesity of Cyprus
University of Cyprus

The University of Cyprus:
• was established by law in 1989 as a body governed by public law;
• admitted its first students in 1992;
• offers a range of undergraduate, postgraduate and vocational programmes;
• has developed a strong research activity (basic and applied) across the whole range of social impact-oriented disciplines;
• is staffed (September 2024 data) with 355 academic staff members, 60 Special Teaching Staff members, 986 postdoctoral researchers, research assistants, academic researchers and Special Scientists, and 498 administrative staff members;
• is on a continuous upward trajectory of success, with the world reputation rankings placing it among the top universities internationally. More specifically: TIMES 2025 (among the top 401-500), QS 2025 (389), Shanghai ranking – ARWU 2024 (701-800), and US Best Global University Rankings 2024-25 (678).
• is a partner of the European university YUFE (Young Universities for the Future of Europe), the European alliance of Young Universities for the Future of Europe.

The organisational entities are housed on the University Campus, in the premises of the former Pedagogical Academy and the Shacolas Educational Centre for Clinical Medicine (former Faculty of Nursing), in a part of a building complex in Latsia, in buildings in the walled city of Nicosia, as well as in a significant number of buildings scattered in the wider area of Nicosia.

More info: https://www.ucy.ac.cy/?lang=en

Partners-22
Cyprus Association of Cancer Patients & Friends (PASYKAF)

Cyprus Association of Cancer Patients & Friends (PASYKAF) is a voluntary, non-governmental health association made up of 5,500 members and 750 volunteers. PASYKAF aims to (i) promote cancer prevention and early detection and (ii) ensure high-quality cancer management, from using the most up to-date prevention practices and organised population screening programmes to high-quality treatment, rehabilitation and palliative care services. Within the cancer control domain, PASYKAF conducts prevention and early detection public awareness campaigns, educating and supporting health professionals and advocating for patients’ rights. Additionally, a dedicated research department is involved in investigating social matters, in collaborative, competitive calls at national, EU and international levels. PASYKAF maintains active memberships in numerous European and global organizations, leveraging its extensive experience in areas like telemedicine and policy advocacy to contribute to project development, exploitation, and sustainability plans, while also promoting advancements in cancer-related healthcare and patient rights through robust local, European, and international collaborations and awareness campaigns.

More info: https://pasykaf.org/

Partners-27
State Health Services Organisation

State Health Services Organisation is the largest Healthcare provider in Cyprus, with 9 hospitals and 38 health centers in all cities and provinces. SHSO hospitals and health centers are available to citizens of all ages, 24 hours a day, with SHSO offering comprehensive health services that cover the full range of health needs of the population throughout Cyprus. The Directorate of Mental Health represents one of the main pillars of the organisation and it offers specialised services through the only Mental Health Services hospital in Cyprus (Athalassa Hospital) and its various MHS structures that are located throughout the country. The SHSO Ambulances Directorate is the connecting link between all the services offered by SHSO that covers geographically the whole of Cyprus with 24 stations and 72 ambulances.
Recognising its great responsibility to play a key role in the health sector, SHSO implements an ambitious reorganisation plan for administrative and financial autonomy, in order to better respond to the new competitive environment of the General Health System. With continuous investment in infrastructure, human resources and research, SHSO is constantly upgraded in order to improve the services it offers.

More info: https://www.shso.org.cy/en/

Partners-22
University of Sarajevo

University of Sarajevo, Bosnia and Herzegovina, is a comprehensive public higher education and research institution, and is a relevant actor and contributor in country’s scientific/research output. Study programmes and research opportunities are offered at 22 faculties, 3 art academies, 5 large scientific-research institutes, and 5 centres, with over 200 departments, thus providing balanced range of academic and professional training and research within social, medical, natural, and technical sciences, humanities and arts. UNSA has extensive experience in international projects within EU, regional, and national funding schemes. With over 500 projects currently active at UNSA 30 member institutions, UNSA is a leading institution in BiH in receiving international research grants and national research funding.
The University of Sarajevo – Faculty of Science (UNSA – FS) is a member of the University of Sarajevo and consist of five departments: Department of physics, Department of Mathematics and Computer Science, Department of Chemistry, Department of Biology and Department of Geography. UNSA – FS is committed to provide excellent education in fundamental sciences for their students, as well as to be national leader in both, theoretical and experimental fundamental sciences research.

More info: https://www.unsa.ba/

GSI
GSI Helmholtzzentrum für Schwerionenforschung Gmbh
Partners-22
German Cancer Research Center, DKFZ

The Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ) is Germany’s lar-gest biomedical research center with a worldwide reputation of excellence in basic and translational cancer research. Established in 1964 as a foundation under public law, the DKFZ today has 3424 staff (870 foreign employees from 86 nations (June 2024)). In 2019, the total budget was 319 million Euros funded by the Federal German Government, the State of Baden-Württemberg and third-party funding. The DKFZ is a member of the Helmholtz Association of German Research Centres – Germany’s largest research organization. The strategic goals of the DKFZ are to contribute towards a better understanding of fundamental processes in cancer and to develop innovative methods of cancer diagnostics and therapy. Research at the DKFZ is divided into 5 main research programs: Cell Biology and Tumor Biology; Functional and Structural Genomics; Cancer Risk Factors and Prevention; Immunology, Infection and Cancer; Imaging and Radiooncology.

More info: https://dkfz.de

CERN
CERN

Physicists and engineers at CERN use the world’s largest and most complex scientific instruments to study the basic constituents of matter – fundamental particles. Subatomic particles are made to collide together at close to the speed of light. The process gives us clues about how the particles interact, and provides insights into the fundamental laws of nature. We want to advance the boundaries of human knowledge by delving into the smallest building blocks of our universe.
The instruments used at CERN are purpose-built particle accelerators and detectors. Accelerators boost beams of particles to high energies before the beams are made to collide with each other or with stationary targets. Detectors observe and record the results of these collisions.Founded in 1954, the CERN laboratory sits astride the Franco-Swiss border near Geneva. It was one of Europe’s first joint ventures and now has 24 member states.